Investor profile
University of Cambridge Venture Fund (Cambridge Enterprise Ventures)
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Cambridge Enterprise Ventures invests University of Cambridge capital into high-impact, high-growth Cambridge spin-outs and start-ups, enabling entrepreneurial academics, students, graduates, and recent alumni by providing early-stage equity investment and hands-on support. The fund is evergreen — all returns are reinvested so that each new Cambridge innovation supports the next — and operates across deep tech, life sciences, sustainability, and social ventures, leveraging a co-investor network of over 100 global partners to achieve a capital leverage ratio of 1:63. The fund focuses on pre-seed and seed stages where securing first investment is most challenging, but follows its money through multiple rounds. As the team states: "We always syndicate with co-investors at seed stage and beyond, seeking the right added-value investors to bring the right cash for each business dependent on its sector and stage of investment." Since 1995, Cambridge Enterprise Ventures has supported over 212 companies, invested £55m in total, and helped portfolio companies raise £3.5bn in follow-on funding.
Notable quotes
“We can invest over £2 million into companies over a number of rounds of investment, following our money through multiple stages of investment.”
“For every £1 that we have invested, £70 has been invested by others. With strong co-investment collaborations and a network of over 100 investors globally, we're able to bring together expertise, resources, and funding to fuel the success of our ventures.”
“Pre-seed and seed funding are critical stages for entrepreneurs to validate their ideas, de-risk their technologies and to develop their commercial plan so that they can attract the investment they will need to continue to scale. We aim to provide key investment in early-stage journeys – and beyond.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Nu Quantum | Series A | $60m | 2025-12-10 |
| Gigaton | Series A | $26m | 2026-06-03 |
| Hacktron | Pre-Seed | $3m | 2026-05-15 |
| TRIMTECH Therapeutics | Seed | $14m | 2026-06-23 |
| Riverlane | Series B | $19m | 2023-04-01 |
| Carbon Re | Seed | — | — |
| Nyobolt | Seed | — | — |
| Cambridge Electric Cement | Seed | — | — |
| Paragraf | Series A | $16m | 2019-07-01 |
| T-Therapeutics | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Amadeus Capital Partners | 8 |
| Cambridge Innovation Capital | 7 |
| Parkwalk Advisors | 6 |
| IQ Capital | 4 |
| Molten Ventures | 3 |
| National Security Strategic Investment Fund (NSSIF) | 2 |
Fit check
Is University of Cambridge Venture Fund (Cambridge Enterprise Ventures) a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit